Innovotech Inc (IOT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Innovotech Inc (IOT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6498
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Innovotech Inc (Innovotech) is a medical device company. The company offers services and solutions to medical, agricultural, and industrial problems caused by microbial biofilms. Its products include InnovoSIL, the antimicrobial agents for coating onto or incorporation into medical devices; MBEC Assay, a screening assay used to determine the efficacy of antimicrobials against biofilms of various microorganisms; and Agress/AgreGuard, an environmentally friendly seed treatments and plant sprays to protect crops against both bacterial and fungal infections. Innovotech also provides cover implant medical devices, bacteriophage and cytotoxicity testing, and in vitro antimicrobial testing, and antibiotic, antimicrobial and biocide resistance. The company serves customers in the areas of biofilm issues including catheter and implant medical devices, wound healing, paint and specialized coatings, and water system antimicrobial agents, among others. Innovotech is headquartered in Edmonton, Alberta, Canada.

Innovotech Inc (IOT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Innovotech Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Innovotech Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Innovotech Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Innovotech Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Innovotech Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Innovotech Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Innovotech Completes Private Placement Of Units For US$0.41 Million 10
Innovotech Raises USD0.5 Million in Private Placement of Units 11
Innovotech Completes Private Placement Of Units For US$0.51 Million 12
Innovotech Inc – Key Competitors 13
Innovotech Inc – Key Employees 14
Innovotech Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Innovotech Inc, Medical Equipment, Key Facts, 2017 2
Innovotech Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Innovotech Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Innovotech Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Innovotech Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Innovotech Inc, Deals By Market, 2012 to YTD 2018 8
Innovotech Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Innovotech Completes Private Placement Of Units For US$0.41 Million 10
Innovotech Raises USD0.5 Million in Private Placement of Units 11
Innovotech Completes Private Placement Of Units For US$0.51 Million 12
Innovotech Inc, Key Competitors 13
Innovotech Inc, Key Employees 14

List of Figures
Innovotech Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Innovotech Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Innovotech Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Innovotech Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Innovotech Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Innovotech Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Innovotech Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Innovotech Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Innovotech Inc (IOT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Laing O’Rourke Plc:企業の戦略的SWOT分析
    Laing O'Rourke Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • The Council of Europe Development Bank:企業の戦略・SWOT・財務分析
    The Council of Europe Development Bank - Strategy, SWOT and Corporate Finance Report Summary The Council of Europe Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Absher Construction Company:企業の戦略・SWOT・財務分析
    Absher Construction Company - Strategy, SWOT and Corporate Finance Report Summary Absher Construction Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Penske Automotive Group, Inc.:企業のM&A・事業提携・投資動向
    Penske Automotive Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Penske Automotive Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Drugs for Neglected Diseases initiative-製薬・医療分野:企業M&A・提携分析
    Summary Drugs for Neglected Diseases initiative (DNDi) is a research center that discovers and develops new drugs. The center develops therapeutics for the treatment of various diseases. It offers treatments which include ASAQ, ASMQ, NECT, SSG&PM and pediatric benznidazole. DNDi also offers products …
  • Bunge Ltd (BG):企業の財務・戦略的SWOT分析
    Bunge Ltd (BG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • PharmaEssentia Corp (6446):製薬・医療:M&Aディール及び事業提携情報
    Summary PharmaEssentia Corp (PharmaEssentia) is a developer of therapeutic products for the treatment of human diseases. The company’s pipeline product includes P1101, a new generation PEG-Interferon-alpha-2b which is developed using PEGylation technology platform. Its pegylation technology platform …
  • Tokuyama Corp (4043):電力:M&Aディール及び事業提携情報
    Summary Tokuyama Corp (Tokuyama), formerly Nihon Soda Kogyo Co., Ltd., manufactures and sells chemicals, specialty products and cement. Its product portfolio includes soda ash, caustic soda, silicon products, vinyl chloride monomer/polymer, fine chemicals, film products, medical materials, methylene …
  • First American Financial Corp:企業の戦略・SWOT・財務情報
    First American Financial Corp - Strategy, SWOT and Corporate Finance Report Summary First American Financial Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • MitoGenetics LLC-製薬・医療分野:企業M&A・提携分析
    Summary MitoGenetics LLC (MitoGenetics) is a biomedical research and development company which produces proprietary compounds and intellectual property for the treatment of human, animal and plant diseases caused due to mitochondrial dysfunction. The company offers technology to regulate cellular mi …
  • CaixaBank SA:戦略・SWOT・企業財務分析
    CaixaBank SA - Strategy, SWOT and Corporate Finance Report Summary CaixaBank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Great Eastern Holdings Limited (G07):企業の財務・戦略的SWOT分析
    Great Eastern Holdings Limited (G07) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • SELLAS Life Sciences Group Inc (SLS):医療機器:M&Aディール及び事業提携情報
    Summary SELLAS Life Sciences Group Inc (SELLAS), formerly Galena Biopharma Inc, is a clinical-stage biopharmaceutical company that develops novel cancer immunotherapeutics for a broad range of cancer indications. Its lead product candidate, galinpepimut-S, is a Wilms Tumor 1 (WT1) protein-targeting …
  • Emirates National Oil Co Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Emirates National Oil Co Ltd (ENOC) is an oil and gas company that offers downstream and upstream activities. The company’s products include liquid petroleum gas, aviation fuel, lubricants, chemicals, and LPG containers. It offers services such as trading, supplying, processing, marketing, t …
  • Kalle GmbH:企業の戦略的SWOT分析
    Kalle GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Applied Genetic Technologies Corp (AGTC):企業の財務・戦略的SWOT分析
    Summary Applied Genetic Technologies Corp (AGTC) is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It offers products such as x-linked retinoschisis, achromatopsia, x-linked retinitis pi …
  • eHealthInsurance Services Inc:企業の戦略的SWOT分析
    eHealthInsurance Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • SiteOne Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SiteOne Therapeutics Inc (SiteOne) is a biopharmaceutical company that develops novel non-opioid pain therapeutics for the treatment of acute and chronic pain. The company’s lead therapeutic candidates include ST-2427 Intravenous, for post-operative pain; ST-SubQ Subcutaneous and ST-Oral, fo …
  • Arma Global Corporation:企業の戦略・SWOT・財務情報
    Arma Global Corporation - Strategy, SWOT and Corporate Finance Report Summary Arma Global Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Surge Global Energy Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Surge Global Energy Inc (Surge Global) is an independent oil and gas exploration, production and trading company. The company acquires, finance and develops oil and gas properties. Its energy and metal commodities comprise natural gas, crude oil, coal, electricity, refined petroleum products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆